Investor Connect

We help Startups and Investors Connect for Funding
Connect - Listen - Invest

Latest Episodes

Startup Funding Espresso – Customer Intimacy in Fundraising
[audio src="https://traffic.libsyn.com/secure/angelconnect/04.customer_intimacy_in_fundraising.mp3"][/audio]Customer Intimacy in Fundraising Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. Customer intimacy is a strategy in which one builds a relationship with the customer about their care abouts and expectations. The more one knows about…
Startup Funding Espresso – Founders Who Got Lucky
[audio src="https://traffic.libsyn.com/secure/angelconnect/03.founders_who_got_lucky.mp3"][/audio]Founders Who Got Lucky Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. Some founders get lucky and achieve a successful exit of their business. They were in the right place at the right time with the right…
Startup Funding Espresso – Your First Round Should Have an Investor-Friendly Valuation
[audio src="https://traffic.libsyn.com/secure/angelconnect/02.your_first_round_shoulf_have_an_investor_friendly_valuation.mp3"][/audio]Your First Round Should Have an Investor-Friendly Valuation Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. In raising funding, the first round is always the hardest. Here's why it's so difficult: There's often no product or revenue…
Startup Funding Espresso – Mitigate the Risks
[audio src="https://traffic.libsyn.com/secure/angelconnect/01.mitigate_the_risks.mp3"][/audio]Mitigate the Risks Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. In a pitch, founders focus on the opportunity while the investors focus on the risk. Founders who raise funding have successfully shown how they mitigate those…
Investor Connect: TEN Connect May 2026 – Part 3
In this episode of Investor Connect, we hear a pitch from Ethair on addressing the global opioid epidemic with ATX-1209, a neuromodulator designed to modulate the mu-opioid receptor by suppressing dependence signals while preserving analgesic benefit when used alongside opioids, with additional development plans for opioid use disorder and neonatal…

To listen to previous episodes, please click on any of the following: Investor Connect, Investor Perspectives, and Startup Espressos.